R&D News | pharmaphorum

News

A globe atlas from above on a white surface

Novartis issues a life sciences warning in a 'G-Zero' world

Novartis claims life sciences lie at the centre of a shift in geopolitics and policies in regions like Europe, Japan, and Canada are "self-defeating."

News

Back of man wearing branded BioInnovation Institute top.

Novo Nordisk Foundation pledges €736m for European biotech

Novo Nordisk Foundation is pumping funding into a Copenhagen-based biotech incubator, seeking to address the challenge of funding access in Europe.

News

EMA and FDA agree 'principles' for AI in drug development

The FDA and EMA have come up with guiding principles that they say will underpin future guidance on the use of AI technologies in drug development.

News

Oxford BioMedica confirms private equity takeover talks

Oxford BioMedica confirmed this morning that it has received an unsolicited approach from private equity group EQT about a possible takeover.

News

JPM: Novo Nordisk CEO gives insight into new strategy

Novo Nordisk CEO Mike Doustdar covers oral Wegovy, DTC sales channels, and an under-appreciated obesity pipeline in a wide-ranging presentation.

News

Hippocratic AI builds in life sciences with Grove AI buy

Hippocratic AI has expanded with the acquisition of Grove AI, a specialist in AI used in pharma R&D, building on its patient-facing GenAI agents.

Novartis issues a life sciences warning in a 'G-Zero' world

Novo Nordisk Foundation pledges €736m for European biotech

EMA and FDA agree 'principles' for AI in drug development

Oxford BioMedica confirms private equity takeover talks

JPM: Novo Nordisk CEO gives insight into new strategy

Hippocratic AI builds in life sciences with Grove AI buy

UK puts £100m into "world-first" AI biosecurity facility

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks